Household Plastics May Disrupt Body Clock Similar to Caffeine

May 14, 2025 | 908 Views

A recent study published in Environmental International suggests that chemicals found in common plastic products such as PVC and polyurethane could interfere with the body’s natural sleep-wake cycle, akin to the effects of caffeine. These plastics disrupt signals in human cells that control alertness and sleep, thereby interfering with the circadian rhythm, according to researchers’ findings. The disruption occurred more quickly than with established hormone-disrupting chemicals. This disruption of the body’s circadian rhythms can raise the likelihood of developing sleep disorders, diabetes, and possibly cancer. Health could be affected over time by common household products made from such plastics, without any warning. The results emphasize the possible concealed threats of commonly utilized plastic substances in everyday life and evoke worries regarding prolonged exposure.

Advanced Therapy in 2-Year-Old Could Revolutionize Thalassemia Management in India

May 09, 2025 | 957 Views

A child was diagnosed with Beta Thalassemia Major at the age of six months — a severe genetic blood condition that hinders the body’s ability to produce sufficient healthy red blood cells. This condition necessitates lifelong blood transfusions and can result in serious health complications if not adequately treated. The family was heartbroken upon understanding that a bone marrow transplant was the only possible cure. The child had a special bone marrow transplant and is now free of thalassemia, thankfully. The child has been granted a new lease on life due to this breakthrough, which has also brought the family immense relief. The case provides hope for numerous children in India afflicted with major thalassemia, demonstrating the life-changing effects of early intervention and state-of-the-art medical treatment.

GenomeIndia: Unlocking India's Genetic Future

Apr 29, 2025 | 747 Views

The GenomeIndia initiative has advanced considerably in the decoding of genetic data that is distinctive to the Indian populace, offering great promise for medical research and healthcare. The initiative conducted genotyping on 10,074 unrelated and healthy individuals from 85 groups—32 tribal and 53 non-tribal—throughout India. Whole genome sequencing was conducted on 9,772 individuals from approximately 20,000 collected blood samples, uncovering more than 180 million genetic variants. Out of these, there were 130 million on autosomes (non-sex chromosomes) and 50 million on sex chromosomes. Some variants are associated with disease, while others are rare or found only in India or certain communities. It is anticipated that these insights will influence future strategies for early diabetes prevention, rare disease management, drug discovery, and AI-driven precision medicine tailored to India’s genetically diverse population.